Una S. Ryan - Jun 5, 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Una S. Ryan
Stock symbol
QNCX
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 09:03 PM
Previous filing
Oct 2, 2023
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.